So somebody with knowledge in the field please speak up to this. We were all mistaken in the phase 1 trial about efficacy, because the study was done on human tissue not human beings so it was impossible to put a percentage mark on it. Now there doing a phase 2 efficacy trial on human beings, so this will be able to put a percentage mark on it. This will be similiar to the percentage mark gwph put on there epilepsy trials that made there stock sky rocket. Am I right by saying this???